Get flash to fully experience Pearltrees
Though my grandson and I are in two different sections of the country and both facing different cancer scares, we share one thing more prominently than anything else.
• Drug Abuse • Feb 29, 2012 A cluster of bleeding episodes in patients treated with dabigatran (Pradaxa) led a group of New Zealand hematologists to express concern and call for better prescriber education. A two-month review identified 78 bleeding episodes, including a dozen major bleeds, one of which might have contributed to a patient’s death, the hematologists wrote in a letter published in the March 1 issue of the New England Journal of Medicine.
The case of a Pradaxa user who died after a minor fall is raising more questions about the drug's safety. As the FDA investigates a series of deaths in Pradaxa patients, a new report in the Journal of Neurosurgery details an 83-year-old man's death from a small brain hemorrhage that quickly grew, and didn't respond to efforts to stop it. "In the event of traumatic hemorrhage in patients receiving dabigatran ... there are currently no effective reversal agents," the report said (as quoted by Reuters ).
Factors raising risk of stroke may also raise the risk of memory loss and… (Ricardo DeAratanha / Los…) Dabigatran (marketed as Pradaxa) is a new drug used by a growing number of Americans with atrial fibrillation. It's both easier to take and more effective at reducing the risk of stroke than warfarin, a drug that's been in use since the 1950s.
Posted by Shezad Malik MD JD March 13, 2012 12:05 AM
Home > Legal News > Fatal G.I. Hemorrhage Prompts Pradaxa Wrongful Death Lawsuit
After recent reports of serious bleeding events and deaths in patients taking Pradaxa, the U.S. Food and Drug Administration (FDA) is now investigating Pradaxa and its potentially deadly side effects . Pradaxa (dabigatran etexilate) was approved in October 2010 by the FDA to reduce the risk of strokes in high-risk patients - or those with atrial fibrillation, a condition that affects about 2 million Americans.
Attorney (866) 735-1102 Ext 701 Posted by Cal Warriner March 20, 2012 10:19 AM
Mar 28 Written by: Independent Staff Writer Wednesday, March 28, 2012 The newest drug approved for use in the treatment of heart valve problems or atrial fibrillation among patients with an increased risk of stroke is the drug Pradaxa, manufactured by Boehringer Ingelheim.
Call 888-377-8900 for a free consultation regarding a Pradaxa lawsuit. Attorney Brendan Flaherty is lead attorney for our Pradaxa lawsuit cases.
PRLog (Press Release) - Apr. 3, 2012 - Injury Lawyer network has launched a Pradaxa Helpline for victims of the anti-coagulant Pradaxa.
09 April 2012 Faith Anderson
The blood-thinning drug Pradaxa (dabigatran) has been linked to a number of serious complications, including an increased risk of serious and in some cases, fatal, bleeding events. Boehringer Ingelheim, the company that manufactures Pradaxa, acknowledged in November 2011 that the drug was responsible for approximatley 260 deaths worldwide.
Home > Legal News > New Blood Thinner Similar to Pradaxa: Risk of Internal Bleeding Merck & Co. has introduced a new blood thinner which is in the same class as Pradaxa and Xarelto, which also poses an increased risk of potentially fatal internal bleeding . This new anticoagulant, Vorapaxar, appears to reduce the risk of a fatal heart attack or stroke by roughly 20% in patients who have already suffered a heart attack.
Home > Legal News > Pradaxa Internal Bleeding Concerns Mount after Patient Dies After an elderly man died from a brain hemorrhage, the Journal of Neurosurgery has suggested that Pradaxa internal bleeding is largely irreversible.